Studies with 873140, a novel CCR5 antagonist, demonstrate synergy with enfuvirtide and potent inhibition of enfuvirtide-resistant R5-tropic HIV-1
Publication
, Conference
LaBranche, CC; Davison, D; Ferris, RG; Koszalka, GW; Demarest, JF; Boone, LR; Greenberg, ML
Published in: ANTIVIRAL THERAPY
January 1, 2005
Duke Scholars
Published In
ANTIVIRAL THERAPY
ISSN
1359-6535
Publication Date
January 1, 2005
Volume
10
Issue
4
Start / End Page
S73 / S73
Location
Quebec City, CANADA
Publisher
INT MEDICAL PRESS LTD
Conference Name
14th International HIV Drug Resistance Workshop
Related Subject Headings
- Virology
- 3207 Medical microbiology
- 3202 Clinical sciences
- 3107 Microbiology
- 1108 Medical Microbiology
- 1103 Clinical Sciences
- 0605 Microbiology
Citation
APA
Chicago
ICMJE
MLA
NLM
LaBranche, C. C., Davison, D., Ferris, R. G., Koszalka, G. W., Demarest, J. F., Boone, L. R., & Greenberg, M. L. (2005). Studies with 873140, a novel CCR5 antagonist, demonstrate synergy with enfuvirtide and potent inhibition of enfuvirtide-resistant R5-tropic HIV-1. In ANTIVIRAL THERAPY (Vol. 10, pp. S73–S73). Quebec City, CANADA: INT MEDICAL PRESS LTD.
LaBranche, C. C., D. Davison, R. G. Ferris, G. W. Koszalka, J. F. Demarest, L. R. Boone, and M. L. Greenberg. “Studies with 873140, a novel CCR5 antagonist, demonstrate synergy with enfuvirtide and potent inhibition of enfuvirtide-resistant R5-tropic HIV-1.” In ANTIVIRAL THERAPY, 10:S73–S73. INT MEDICAL PRESS LTD, 2005.
LaBranche CC, Davison D, Ferris RG, Koszalka GW, Demarest JF, Boone LR, et al. Studies with 873140, a novel CCR5 antagonist, demonstrate synergy with enfuvirtide and potent inhibition of enfuvirtide-resistant R5-tropic HIV-1. In: ANTIVIRAL THERAPY. INT MEDICAL PRESS LTD; 2005. p. S73–S73.
LaBranche, C. C., et al. “Studies with 873140, a novel CCR5 antagonist, demonstrate synergy with enfuvirtide and potent inhibition of enfuvirtide-resistant R5-tropic HIV-1.” ANTIVIRAL THERAPY, vol. 10, no. 4, INT MEDICAL PRESS LTD, 2005, pp. S73–S73.
LaBranche CC, Davison D, Ferris RG, Koszalka GW, Demarest JF, Boone LR, Greenberg ML. Studies with 873140, a novel CCR5 antagonist, demonstrate synergy with enfuvirtide and potent inhibition of enfuvirtide-resistant R5-tropic HIV-1. ANTIVIRAL THERAPY. INT MEDICAL PRESS LTD; 2005. p. S73–S73.
Published In
ANTIVIRAL THERAPY
ISSN
1359-6535
Publication Date
January 1, 2005
Volume
10
Issue
4
Start / End Page
S73 / S73
Location
Quebec City, CANADA
Publisher
INT MEDICAL PRESS LTD
Conference Name
14th International HIV Drug Resistance Workshop
Related Subject Headings
- Virology
- 3207 Medical microbiology
- 3202 Clinical sciences
- 3107 Microbiology
- 1108 Medical Microbiology
- 1103 Clinical Sciences
- 0605 Microbiology